Market Tracker

10/23 3:40am ET

Merck & Co Inc (NYSE:MRK)

63.88
Delayed Data
As of Oct 20
 +0.13 / +0.20%
Today’s Change
58.29
Today|||52-Week Range
66.80
+8.51%
Year-to-Date
Roche (RHHBY) Reports Sales Numbers for First 9 Months
Oct 20 / Zacks.com - Paid Partner Content
J&J (JNJ) Beats on Q3 Earnings, Actelion Buyout Drives Sales
Oct 17 / Zacks.com - Paid Partner Content
Celgene Down on Discontinued Crohn's Disease Drug Study
Oct 20 / Zacks.com - Paid Partner Content
Bristol-Myers Gets Priority Review for Opdivo Label Expansion
Oct 17 / Zacks.com - Paid Partner Content
Cancer Treatment Update: Second Gene Therapy Receives Approval
Oct 20 / Zacks.com - Paid Partner Content
Bowling Portfolio Management LLC Buys Merck Inc, Micron Technology Inc, Thor Industri...
Oct 16 / GuruFocus News - Paid Partner Content
BioLineRx/Roche Scan BL-8040-Tecentriq for Gastric Cancer
Oct 20 / Zacks.com - Paid Partner Content
Bowling Portfolio Management LLC Buys Merck Inc, Micron Technology Inc, Thor Industri...
Oct 16 / GuruFocus News - Paid Partner Content
Shell Asset Management Co Buys SPDR S&P 500, iShares MSCI ACWI Index Fund, Johnson & ...
Oct 20 / GuruFocus News - Paid Partner Content
Cancer Space Update: Lung & Breast Cancer Studies in Focus
Oct 13 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Beat & Raise Quarter from J&J, Allergan Hit by Restasis Ruling
Oct 20 / Zacks.com - Paid Partner Content
Pharma Stock Roundup: Pfizer Mulls Options for Consumer Healthcare, LLY's Pipeline Se...
Oct 13 / Zacks.com - Paid Partner Content
E&G Advisors, LP Buys BlackRock Multi-Sector Income Trust, AllianzGI Convertible & .....
Oct 20 / GuruFocus News - Paid Partner Content
Merck Will Not Seek Approval for CETP Inhibitor Anacetrapib
Oct 12 / Zacks.com - Paid Partner Content
Why Are These 6 Dow Stocks Fairly Valued?
Oct 19 / GuruFocus News - Paid Partner Content
Seattle Genetics Inks Clinical Collaborations for Cancer Drug
Oct 12 / Zacks.com - Paid Partner Content
AstraZeneca's sNDA for Two Cancer Drugs Gets Priority Review
Oct 19 / Zacks.com - Paid Partner Content
Lilly's (LLY) Verzenio Fails in Phase III Lung Cancer Study
Oct 11 / Zacks.com - Paid Partner Content
Soon, there will be just 3 black Fortune 500 CEOs
Oct 19 / CNNMoney.com
Seattle Genetics Begins Phase II Study of Cancer Candidate
Oct 11 / Zacks.com - Paid Partner Content
Pricing Pressure, Competition Remain Headwinds for Pharma Stocks
Oct 18 / Zacks.com - Paid Partner Content
Company News For Oct 11, 2017
Oct 11 / Zacks.com - Paid Partner Content
What to Expect from Big Pharmas After J&J's Solid Q3 Results?
Oct 18 / Zacks.com - Paid Partner Content
Decoding cancer: hopes rise for a new age of precision medicine
Oct 10 / FT.com - Paid Partner Content
Merck Stock Edges Higher as Citi Forecasts Strong Sales
Oct 18 / TheStreet.com - Paid Partner Content
5 Pharma & Biotech Stocks That Could Be Big Winners in Q3 Earnings
Oct 10 / Zacks.com - Paid Partner Content
Shell Asset Management Co Buys SPDR S&P 500, iShares MSCI ACWI Index Fund, Johnson & ...
Oct 18 / GuruFocus News - Paid Partner Content
AstraZeneca chief confident risks will pay off
Oct 09 / FT.com - Paid Partner Content
Inverness Counsel Inc Buys CVS Health Corp, JPMorgan Chase, Corning Inc, Sells Dover...
Oct 17 / GuruFocus News - Paid Partner Content
Puerto Rico after the storm: an island on the edge
Oct 08 / FT.com - Paid Partner Content